推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 10月31日晚間龍蟒佰利發(fā)出公告，公司全資子公司佰利聯(lián)(香港)有限公司與巴西MINERA..O SANTA ELINA集團(tuán)公司于2017年7月31日簽訂《RGM項(xiàng)目備忘錄》，擬取得RGM項(xiàng)目的控制權(quán)。合作雙方簽署備忘錄后，公司即開始了對(duì)RGM項(xiàng)目的全面盡調(diào)工作。經(jīng)對(duì)RGM項(xiàng)目的多方考察、調(diào)研、論證及分析，公司認(rèn)為該項(xiàng)目無(wú)法滿足公司未來(lái)的發(fā)展需求，經(jīng)過(guò)雙方友好協(xié)商終止了該項(xiàng)目的合作計(jì)劃?！ ?/p>
早在2017年8月3日龍蟒佰利發(fā)出公告,公司的全資子公司佰利聯(lián)(香港)有限公司與巴西MINERA CAO SANTA ELINA集團(tuán)公司于2017年7月31日簽訂《RGM項(xiàng)目備忘錄》,擬取得RGM項(xiàng)目的控制權(quán),并與MSE集團(tuán)就RGM項(xiàng)目的開發(fā)運(yùn)營(yíng)活動(dòng)展開合作。
那時(shí)業(yè)內(nèi)人認(rèn)為，龍蟒佰利取得對(duì)RGM項(xiàng)目的控制權(quán),能夠以低于市場(chǎng)平均價(jià)格獲得滿足富鈦料項(xiàng)目和氯化法項(xiàng)目生產(chǎn)所需要的鈦礦,從而降低公司鈦白粉產(chǎn)品的生產(chǎn)成本,提高公司產(chǎn)品的競(jìng)爭(zhēng)優(yōu)勢(shì);通過(guò)實(shí)施后向一體化戰(zhàn)略,能夠?yàn)楣局\求新的利潤(rùn)增長(zhǎng)點(diǎn)。
顯然，如今與當(dāng)初的預(yù)期相背離！
